United States · FDA National Drug Code directory
Irbesartan and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-057_f2ef667a-4871-4f28-a0b3-3f79fbbe180c
- Product NDC
- 33342-057
- Form
- TABLET, FILM COATED
- Composition / generic term
- Irbesartan and Hydrochlorothiazide
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120927
- Source listing expiry
- 20261231
Source-listed ingredients
- IRBESARTAN — 150 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (33342-057-06) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 33342-057-06
- 30 TABLET, FILM COATED in 1 BOTTLE (33342-057-07) · 33342-057-07
- 90 TABLET, FILM COATED in 1 BOTTLE (33342-057-10) · 33342-057-10
- 500 TABLET, FILM COATED in 1 BOTTLE (33342-057-15) · 33342-057-15
- 9 BLISTER PACK in 1 CARTON (33342-057-39) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 33342-057-39
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →